Intensified follow-up to improve bowel symptoms after rectal cancer surgery
Tests an intensified follow-up program in adults with bowel symptoms after rectal cancer surgery.
Plain-language title generated from the registry record
Registry title: Improving Functional Outcomes and Quality of Life in Patients With Rectal Cancer After Surgery With Intensified Follow-up & Surveillance
Key facts
- Where
- Basel, Bern, Lucerne, and Winterthur, SwitzerlandSee the 5 sites
- Phase
- Phase 3
Where in Switzerland
- Clarunis Universitäres Bauchzentrum BaselBasel, SwitzerlandTaking people
- Lindenhofspital BernBern, SwitzerlandTaking people
- St. Anna Spital BernBern, SwitzerlandNot yet recruiting
- Kantonsspital LuzernLucerne, SwitzerlandTaking people
- Kantonsspital WinterthurWinterthur, SwitzerlandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Basel, Switzerland
- Trial code
- NCT06936774
- Record updated
- 6 May 2026
- Original description
The goal of this clinical study is to gain further insights into the treatment of patients with Low Anterior Resection Syndrome (LARS) symptoms after rectal resection. The main question is: Can LARS symptoms and quality of life be improved by implementing an intensified follow-up program? Researchers will compare the results of the intervention group with the results of a control group in which patients do not receive an intensified follow-up program to determine whether the intervention works. Participants will undergo an intensified follow-up program which consists of several follow-up visits and medical treatment, pelvic floor muscle training and gynaecological and urological co-treatment in case of LARS symptoms and urinary or sexual complaints.Read full original descriptionShow less
Improving Functional Outcomes and Quality of Life in Patients With Rectal Cancer After Surgery With Intensified Follow-up & Surveillance - a Randomized Controlled Trial (iRECOVER)
The goal of this clinical study is to gain further insights into the treatment of patients with Low Anterior Resection Syndrome (LARS) symptoms after rectal resection. The main question is: Can LARS symptoms and quality of life be improved by implementing an intensified follow-up program? Researchers will compare the results of the intervention group with the results of a control group in which patients do not receive an intensified follow-up program to determine whether the intervention works. Participants will undergo an intensified follow-up program which consists of several follow-up visits and medical treatment, pelvic floor muscle training and gynaecological and urological co-treatment in case of LARS symptoms and urinary or sexual complaints.
Inclusion: patients older than 18 years; patients with rectal cancer in the middle and lower third of the rectum in stages I to IV who underwent LAR with TME and protective ileostomy; able to give informed consent as documented by signature.
Exclusion: dementia or other psychiatric disorder that would prevent the patients from answering the questionnaires and experiencing sustainable training effects; impossibility of stoma reversal due to persistent anastomotic leak and/or local recurrence.